Table 3. Changes in efficacy measures from baseline to week 16 (full analysis set).

Variable	Baseline (wk 0) (n=35)	Wk 16 (n=35)	Change from baseline (%)	p value
Total cholesterol (mg/dL)	229.6±27.9	153.3± 31.0	−33.2±10.9	<0.001*
Triglyceride (mg/dL)	147.7±75.0	116.1±60.7	−24.2±37.5	0.001*
HDL-C (mg/dL)	57.1±14.2	56.4±13.8	−1.2±15.3	0.642*
LDL-C (mg/dL)	146.7±25.5	79.4±24.7	−45.8±16.7	<0.001*
apoB (mg/dL)	113.0±19.6	73.5±19.5	−34.9±15.6	<0.001*
apoAI (mg/dL)	150.8±22.9	150.8±23.3	0.0±11.8	0.999*
hsCRP (mg/L)	0.1±0.1	0.1±0.2	28.1±206.7	0.426†

Data are shown as mean±standard deviation.

HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; apoB, apolipoprotein B; apoAI, apolipoprotein AI; hsCRP, high sensitivity C-reactive protein.

^*Paired t-test; ^†Wilcoxon's signed-rank test.